We are disciplined
game-changers

adopting an inclusive,
non-traditional model

We are disciplined
game-changers

adopting an inclusive,
non-traditional model

We are disciplined
game-changers

adopting an inclusive,
non-traditional model

What is Infusion 51A?

Infusion 51a is an impact investment fund backing the development of biotech-based solutions that were once a dream.

Since 2015, the fund has been allocating both financial and human capital into vetted opportunities with the potential to disrupt the life-science ecosystem and create revolutionary alternatives for people all around the world.

We lead great ideas from inception to reality.

We’re not your normal investors

For us, your word is gold. We are determined to create solid relationships based on integrity and mutual trust. We protect our people fiercely, supporting our portfolio companies, and standing up for our shareholders.

We know that we cannot address all global issues, but we can do our best to make huge contributions to revolutionizing healthcare and human life experience.

Our actions is our legacy and we aim to leave the world a better place than when we started! We hope you’ll join us on our mission.

What is Infusion 51A?

Infusion 51a is an impact investment fund backing the development of biotech-based solutions that were once a dream.

Since 2015, the fund has been allocating both financial and human capital into vetted opportunities with the potential to disrupt the life-science ecosystem and create revolutionary alternatives for people all around the world.

We lead great ideas from inception to reality.

We’re another breed of investors​

For us, your word is gold. We are determined to create solid relationships based on integrity and mutual trust. We protect our people fiercely, supporting our portfolio companies, and standing up for our shareholders.

We know that we cannot address all global issues, but we can do our best to make huge contributions to revolutionizing healthcare and human life experience.

Our actions is our legacy and we aim to leave the world a better place than when we started! We hope you’ll join us on our mission.

We provide promising leaders with the vital capital needed to succeed

Our game-changing DNA

1

We are adaptable but not malleable

We adapt our processes and decisions when necessary, embracing that change is inherent to moving forward; yet, under no circumstances will our ethics and culture be compromised or tread on.

4

We are different! We’re not afraid to say it!

Any business can chase profits and margins, but ours purposefully seeks out community based opportunities in addition to our investments.

2

We believe in what we do​

We do our jobs with passion and dignity because entire families depend on the decisions we make today.

5

We are the possessors of a disciplined winning mentality​

We are determined, focused and never take our eyes off the prize. Our discipline and dedicated mentality is our superpower, easily observable in each and every member of our team.

3

We are resilient​

We understand no journey is without its pitfalls. We know that the only way to get where we want to be is by taking steps without apprehension and continuously learning.

Our game-changing DNA

1

We are adaptable but not malleable

We adapt our processes and decisions when necessary, embracing that change is inherent to moving forward; yet, under no circumstances will our ethics and culture be compromised or tread on.

2

We believe in what we do​​

We do our jobs with passion and dignity because entire families depend on the decisions we make today.

3

We are resilient​

We understand no journey is without its pitfalls. We know that the only way to get where we want to be is by taking steps without apprehension and continuously learning.

4

We are different! We’re not afraid to say it!

Any business can chase profits and margins, but ours purposefully seeks out community based opportunities in addition to our investments.

5

We are the possessors of a disciplined winning mentality​

We are determined, focused and never take our eyes off the prize. Our discipline and dedicated mentality is our superpower, easily observable in each and every member of our team.

Make an impact with your investment

Make an impact with your investment

Our Team

General Partners

We are living proof of what hard work can accomplish. We’ve built businesses from the ground up and successfully navigated through all kinds of challenges. Our journey has taught us not to settle for the ordinary and to always rise to the challenges of the future.

Jeff Stephens

General Partner

Scott VanderMeer, MBA

General Partner

Fund and Portfolio Operations

Our diverse and experienced employees are the backbone of Infusion 51a. Each and every member of our organization brings a wealth of knowledge in their chosen fields. It’s this knowledge that enables us to do what we do, and do it well!

Brett Logan, JD

Securities Counsel

Elise Brownell

Program Planning and Integration Director at Vivacitas Oncology

Jeffrey Busch

Theralink Chairman

Krishn Patel

Director of Data Collection

Mark Suseck

Director of Vivacitas Oncology

Todd Smith, MBA

Chief Commercial Officer

Mick Ruxin, M.D

Director and CMO of Theralink Technologies

Monica Coleman, CPA

Finance Consultant

Advisors
Scientific and Medical Advisors

Our consultants are globally recognized industry veterans whose experience spans up to four decades, serving as a source of unsurpassed wisdom and strategic thinking.

Amir Baluch, MD

Medical Advisor

Bill Coleman

Scientific Advisor

Stefan Proniuk PhD, MBA

Product Development Advisor

Paul Manley, BSc

Regulatory Advisor

Emmanuel Petricoin, PhD

Scientific Advisor​

Justin Davis, PhD

Laboratory Director at Theralink Technologies

Heng Fai Chan

CEO at Alset International

Orion Henry

Founder, Heroku Software

Min Sung Park, PhD

CSO, Sanimed Group, IHC. Founding Director, UAE National Genome Program.​

Khalid Fakhro, PhD

Chief Research Officer, Sidra Medicine Qatar.

Yoav Gilad, PhD

Dean for Biomedical and Health Informatics, University of Chicago.

Emmanuel Makasa, MD

Medical Advisor, Deputy Director for Emergency Health Services of Zambia.

Bill Coleman, PhD

Executive Officer of the American Society for Investigative Pathology

Have questions?

Have questions?